RxDoctor Payments Data

Kasey Rangan

Pediatrics · Los Angeles, CANPI 1447573167

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $66,428 of the $107,239 with a category attached, or 61.9%. AstraZeneca accounts for 98.2% of it on its own, with 8 other manufacturers making up the rest. Among pediatrics clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$107,239in general payments, 2019–2025

Across 177 payments — averaging $605.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$105K
  • Day One Biopharmaceuticals$980
  • Servier Pharmaceuticals LLC$278
  • Emmaus Medical, Inc.$125
  • Bayer$123
  • Daiichi Sankyo Inc.$106
  • plus $280 from 3 others

What the payments were for

  • Consulting fees$14,61014%
  • Speaking & faculty fees$66,42862%
  • Travel & lodging$22,46621%
  • Food & beverage$3,7363%

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$107,239 in reported general payments places this provider in the 95th percentile of 5,539 pediatrics providers in California.

See all pediatrics providers in California →

Other pediatrics in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →